This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved.
Disclosure: this site does not earn commission on outbound provider links. Rankings are computed from the published dataset and can be reproduced from it.
Written by Kim Callender, NP, FNP-BC·Reviewed by Jonathan Snipes, MD·Published 2026-02-23·Last reviewed 2026-02-23·Prices verified 2026-02-23·Methodology v1.0

Zepbound self-pay pricing set at $299 to $449 by dose

The starter dose drops to $299 and higher doses to $449, on a 45-day refill condition most coverage omits.

Self-pay vial pricing runs $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg and above, conditional on refilling within 45 days of the previous delivery.

Miss that window and the standard self-pay price applies for that refill, which turns a predictable brand price into an unpredictable one if a delivery slips.

At the starter dose this is competitive with several compounded programmes. At maintenance it remains roughly double the cheapest verified compounded route.

What this changes for what you pay

Most developments in this category move one of three things: the price of the branded product, which programmes are operating, or what may lawfully be compounded. Very few change the prescription requirement or the clinical review behind a prescription.

Where a development moves a figure we publish, the change is recorded with its date on our methodology page rather than edited in silently.

How to verify this yourself

Regulatory claims should be checked against the agency rather than coverage of the agency. FDA publishes warning letters searchable by company name and a drug shortage database, both free and both more current than any summary.

Frequently asked questions

When did this happen?
Dated 2026-02-23. We record the date of the development rather than the date we wrote about it.
Does this change what I can be prescribed?
Almost never. Developments in this category usually change price, availability or what may lawfully be compounded at scale, not the prescription requirement itself.
Is compounded GLP-1 still legal?
Yes, under patient-specific compounding. The scope narrowed after the 2024 and 2025 shortage resolutions and is considerably narrower than it was in 2024.